|
Historical perspectives on myelodysplastic syndromes
|
Aug 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
The impact of hypomethylating agents on the cost of care and survival of elderly patients with myelodysplastic syndromes
|
Aug 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Under-recognition of Platelet dysfunction in Myelodysplastic Syndromes: are we only seeing the tip of the iceberg?
|
Aug 2012
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
The immunomodulatory agents lenalidomide and thalidomide for treatment of the myelodysplastic syndromes: A clinical practice guideline.
|
Aug 2012
|
Crit Rev Oncol Hematol
|
aplastic anemia
|
|
Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes
|
Aug 2012
|
J Clin Oncol
|
myelodysplastic syndromes (MDS)
|
|
Spontaneous remision of aplastic anemia occurring during a pregnancy
|
Aug 2012
|
Ann Biol Clin (Paris)
|
aplastic anemia
|
|
Late Effects in Hematopoietic Cell Transplant Recipients with Acquired Severe Aplastic Anemia: A Report from the Late Effects Working Committee of the Center for International Blood and Marrow Transplant Research
|
Aug 2012
|
Biol Blood Marrow Transplant
|
aplastic anemia
|
|
Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes
|
Aug 2012
|
Am J Hematol
|
myelodysplastic syndromes (MDS)
|
|
SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes
|
Jul 2012
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Cytogenetic risk stratification in myelodysplastic syndromes: are we there yet?
|
Jul 2012
|
J Clin Oncol
|
myelodysplastic syndromes (MDS)
|
